Evidence map›Paper›PMID 29744367›Full record

ArticleJournal of diabetes research2018

AGE/RAGE-Induced EMP Release via the NOX-Derived ROS Pathway.

Ying-Hua Chen, Zhang-Wei Chen, Hong-Mei Li, Xin-Feng Yan, Bo Feng

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Mechanistic Study ofDrug design, development and therapy · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ying-Hua ChenDepartment of Endocrinology, East Hospital, Tongji University, Shanghai 200120, China.
Zhang-Wei ChenDepartment of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Hong-Mei LiDepartment of Endocrinology, East Hospital, Tongji University, Shanghai 200120, China.
Xin-Feng YanDepartment of Endocrinology, East Hospital, Tongji University, Shanghai 200120, China.ORCID 0000-0003-2000-1628
Bo FengDepartment of Endocrinology, East Hospital, Tongji University, Shanghai 200120, China.ORCID 0000-0002-3997-5679
Shanghai East Hospital · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDiabetes is associated with accelerated formation of advanced glycation end products (AGEs) that are extensively found in circulating endothelial microparticles (EMPs). This study aimed to investigate whether AGEs have a direct effect on EMP formation and the possible underlying mechanism.

methodsIn vitro, cultured human umbilical vein endothelial cells (HUVECs) were incubated with AGEs (200 and 400

resultsThe number of EMPs was significantly increased in HUVECs stimulated by AGEs in a dose-dependent manner. In addition, receptors for AGEs (RAGE), NAD(P)H oxidase (NOX), and reactive oxygen species (ROS) were increased by AGEs as compared to the control group. These changes could be reversed when HUVECs were pretreated with anti-RAGE antibody. Moreover, inhibition of NOX as well as antioxidant treatment reduced the release of EMPs induced by AGEs.

conclusionOur study suggested that AGEs increased EMP generation, which was mediated by RAGE signaling through NOX-derived ROS.

Indexed as

AntibodiesAntioxidantsCell-Derived MicroparticlesFlow CytometryGlycation End Products, AdvancedHumansHuman Umbilical Vein Endothelial CellsNADPH OxidasesOxidative StressReactive Oxygen SpeciesReceptor for Advanced Glycation End ProductsSignal TransductionAntibodiesAntioxidantsGlycation End Products, AdvancedNADPH OxidasesReactive Oxygen SpeciesReceptor for Advanced Glycation End Products

Identifiers

PMID29744367
PMCPMC5878883
OpenAlexW2790819275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.